93 related articles for article (PubMed ID: 14680600)
21. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.
Franceschi S; Montella M; Polesel J; La Vecchia C; Crispo A; Dal Maso L; Casarin P; Izzo F; Tommasi LG; Chemin I; Trépo C; Crovatto M; Talamini R
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):683-9. PubMed ID: 16614109
[TBL] [Abstract][Full Text] [Related]
22. Smoking and hepatitis B-negative primary hepatocellular carcinoma.
Trichopoulos D; MacMahon B; Sparros L; Merikas G
J Natl Cancer Inst; 1980 Jul; 65(1):111-4. PubMed ID: 6248671
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
24. Dietary risk factors for primary hepatocellular carcinoma.
Wogan GN
Cancer Detect Prev; 1989; 14(2):209-13. PubMed ID: 2559796
[TBL] [Abstract][Full Text] [Related]
25. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
27. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
28. [An epidemiologic study on the aetiological factors of primary liver cancer in Shunde City of Guangdong province].
Wang ZJ; Zhou YP; Cheng B
Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Jun; 17(3):141-4. PubMed ID: 9208509
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles.
Yu MC; Mack T; Hanisch R; Peters RL; Henderson BE; Pike MC
Cancer Res; 1983 Dec; 43(12 Pt 1):6077-9. PubMed ID: 6315225
[TBL] [Abstract][Full Text] [Related]
30. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
Shiota G; Oyama K; Udagawa A; Nomi T; Tanaka K; Tsutsumi A; Noguchi N; Okano J; Kishimoto Y; Kanbe T; Kishimoto H; Kawasaki H
Hepatogastroenterology; 2009; 56(94-95):1516-20. PubMed ID: 19950820
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of hepatitis B in Canadian blood donors.
O'Brien SF; Xi G; Fan W; Yi QL; Fearon MA; Scalia V; Goldman M
Transfusion; 2008 Nov; 48(11):2323-30. PubMed ID: 18647366
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma.
Chen CH; Chen YY; Chen GH; Yang SS; Tang HS; Lin HH; Lin DY; Lo SK; Du JM; Chang TT; Chen SC; Liao LY; Kuo CH; Lin KC; Tai DI; Changchien CS; Chang WY; Sheu JC; Chen DS; Liaw YF; Sung JL
J Hepatol; 2004 Apr; 40(4):653-9. PubMed ID: 15030982
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
[TBL] [Abstract][Full Text] [Related]
35. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
Yuen MF; Wong DK; Sablon E; Tse E; Ng IO; Yuan HJ; Siu CW; Sander TJ; Bourne EJ; Hall JG; Condreay LD; Lai CL
Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.
Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Takahashi I; Chayama K
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):846-54. PubMed ID: 18398026
[TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
38. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
[TBL] [Abstract][Full Text] [Related]
39. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
[TBL] [Abstract][Full Text] [Related]
40. [A population-based case control study of primary liver cancer in Fusui].
Zhang MD
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):14-8. PubMed ID: 8504447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
